M R Ambrosio Selected Research

M R Ambrosio Research Topics

Disease

5	Acromegaly 05/2018 - 09/2001
4	Neoplasms (Cancer) 02/2021 - 10/2005
4	Hypopituitarism (Sheehan's Syndrome) 10/2012 - 01/2000
2	Body Weight (Weight, Body) 02/2021 - 05/2001
2	Pituitary Neoplasms (Pituitary Adenoma) 07/2008 - 10/2005
1	Liver Diseases (Liver Disease) 07/2022
1	COVID-19 05/2022
1	Amenorrhea 09/2019
1	Infertility (Sterility) 09/2019
1	Cysts 03/2016
1	Wounds and Injuries (Trauma) 10/2015
1	Pathologic Processes 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Leiomyomatosis 01/2014
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 10/2012
1	Cytomegalovirus Infections (Inclusion Disease) 02/2012
1	Appendicitis 02/2012
1	Diverticulitis 02/2012
1	Intestinal Obstruction (Obstruction, Intestinal) 02/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2012
1	Adenocarcinoma 12/2011
1	Signet Ring Cell Carcinoma 04/2009
1	Stroke (Strokes) 09/2008
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 02/2008
1	Brain Neoplasms (Brain Tumor) 06/2006
1	Adenoma (Adenomas) 10/2005
1	Prolactinoma (Prolactinomas) 10/2005
1	Growth Hormone-Secreting Pituitary Adenoma 10/2005
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2005
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2004
1	Pituitary Diseases (Disease, Anterior Pituitary) 06/2004
1	Hypertension (High Blood Pressure) 09/2001
1	Insulin Resistance 09/2001
1	Overweight 05/2001
1	Combined Pituitary Hormone Deficiency 01/2000

Drug/Important Bio-Agent (IBA)

8	Insulin-Like Growth Factor I (IGF-1)IBA 07/2022 - 01/2000
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2018 - 10/2005
3	Growth Hormone (Somatotropin)IBA 07/2008 - 06/2004
2	Pharmaceutical PreparationsIBA 02/2021 - 09/2019
2	pegvisomant FDA LinkGeneric 05/2018 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 03/2016 - 12/2011
2	Hormones (Hormone)IBA 12/2011 - 09/2008
1	Testosterone (Sustanon)FDA Link 05/2022
1	LipidsIBA 02/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 09/2019
1	Opioid Analgesics (Opioids)IBA 09/2019
1	Antidepressive Agents (Antidepressants)IBA 09/2019
1	Antipsychotic Agents (Antipsychotics)IBA 09/2019
1	AlginatesIBA 10/2015
1	Hyaluronic Acid (Hyaluronan)IBA 10/2015
1	Polysaccharides (Glycans)IBA 10/2015
1	HydrogelsIBA 10/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2014
1	Tuberculin (PPD)IBA 01/2014
1	AntibodiesIBA 10/2012
1	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2012
1	Oral ContraceptivesIBA 02/2012
1	Fibrinogen (Factor I)FDA Link 12/2011
1	Amyloid (Amyloid Fibrils)IBA 04/2009
1	lanreotide (Somatuline)FDA Link 03/2009
1	Arginine (L-Arginine)FDA Link 06/2006
1	Dopamine (Intropin)FDA LinkGeneric 10/2005
1	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2005
1	ProlactinIBA 10/2005
1	BIM-23244IBA 10/2005
1	Dopamine Receptors (Dopamine Receptor)IBA 10/2005
1	BIM 23120IBA 10/2005
1	BIM 23206IBA 10/2005
1	Chromogranin AIBA 07/2005
1	SodiumIBA 09/2001
1	Estrogens (Estrogen)FDA Link 05/2001
1	somatotropin-binding protein (growth hormone-binding protein)IBA 05/2001
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2001
1	Dehydroepiandrosterone (DHEA)IBA 01/2000
1	Dehydroepiandrosterone SulfateIBA 01/2000

Therapy/Procedure

4	Therapeutics 02/2021 - 06/2004
1	Drug Therapy (Chemotherapy) 02/2012
1	Injections 03/2009
1	Critical Care (Surgical Intensive Care) 02/2008
1	Radiotherapy 06/2004